Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, play a crucial role in glucose metabolism by enhancing the glucose-dependent secretion of insulin from pancreatic beta cells and inhibiting glucagon release from alpha cells, thus lowering blood glucose levels postprandially (Holst, 2007)
Current European Society of Cardiology and American Heart Association guidelines prioritize SGLT2 inhibitors for HFrEF, reserving GLP-1 agents mainly for glycemic and weight control rather than heart failure treatment
This can vary greatly from brand to brand
Anastrozole is a medication classified as an aromatase inhibitor , licensed in the UK for the treatment of hormone receptor-positive breast cancer in postmenopausal women
One prevents reflux problems
Do not stop taking Ozempic without medical advice , even if you are concerned about thyroid effects